Phenomune

What Phenomune does

Phenomune, LLC is a Houston, Texas-based private biotechnology company founded in 2021 that develops and distributes an at-home immune profiling test kit based on bitter taste receptor (T2R) phenotype detection. The product consists of four taste test strips that, when activated via QR code and processed through the company's HIPAA-compliant iOS and Android mobile app, deliver personalized insights into an individual's innate upper respiratory defense capabilities against respiratory illnesses including flu, COVID-19, and bronchitis within minutes, without requiring samples or lab work.

The underlying technology is grounded in peer-reviewed research, including a JAMA Network Open cohort study of more than 2,000 participants linking T2R phenotype to COVID-19 clinical outcomes, and the company's scientific work has been featured in JAMA, the Washington Post, Business Insider, National Geographic, the Viruses Journal, the American Journal of Rhinology & Allergy, and the International Forum of Allergy & Rhinology. The company is physician-founded by Dr. Henry P. Barham, MD, FARS (an internationally recognized rhinologist with 150+ peer-reviewed publications) and co-founded by Dr. James R. White Jr., MD (a Mayo Clinic-trained ENT physician).

Phenomune operates a hybrid go-to-market combining direct-to-consumer distribution through phenomune.com and the mobile app, healthcare provider ordering with clinical outreach support to hospitals, nursing homes, FQHCs, and community clinics, and a flagship government partnership with the Louisiana Department of Health launched in June 2026 to distribute up to 250,000 free test kits statewide under Governor Jeff Landry's endorsement. Commercial pricing has not been publicly disclosed, the offering is currently free through the Louisiana pilot, and the company maintains regulatory compliance across HIPAA, GDPR, CCPA, WCAG 2.1 AA, Section 508, and ADA Title II.

Name

Phenomune

Legal name

Phenomune, LLC

Website

https://phenomune.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Phenomune is a Houston-based biotech company that sells an at-home bitter taste receptor (T2R) test kit and HIPAA-compliant mobile app to assess individuals' innate upper respiratory immune defense, serving Louisiana residents through a state partnership and healthcare providers nationwide.

Ownership category

akta.pro rank

Product category

At-Home Immune Profiling Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

• At-home immune profiling
• Bitter taste receptor testing
• Respiratory wellness diagnostics
• Noninvasive taste test kit
• Preventive health testing

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Operations

Revenue model

1. At-Home Immune Test Kits: Sale or distribution of taste-based test kits that provide personalized immune insights. Currently offered free through Louisiana pilot program; commercial availability unclear.
2. Mobile App Services: HIPAA-compliant mobile app delivers test results and personalized wellness recommendations. App available on iOS and Android platforms.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Phenomune sells an at-home immune profiling test kit that uses bitter taste receptor (T2R) phenotypes to assess an individual's innate upper respiratory defense capabilities against illnesses such as flu, COVID-19, and bronchitis. The four-strip test kit pairs with a HIPAA-compliant iOS/Android mobile app activated by QR code that delivers personalized wellness insights within minutes — requiring no samples and no lab work.

Product overview

Phenomune offers a unified wellness platform centered on immune profiling through bitter taste receptor (T2R) phenotype assessment. The core offering consists of the Phenomune Test Kit (a four-strip at-home taste test that requires no samples or lab work) paired with the Phenomune Mobile App (a HIPAA-compliant iOS/Android application that guides users through testing, delivers personalized results within minutes, and provides wellness recommendations). The platform leverages peer-reviewed research linking T2R receptors to innate upper respiratory defense, providing users with insights into their body's natural defenses against respiratory illnesses. Phenomune operates primarily as a direct-to-consumer and healthcare provider wellness tool, with recent expansion into population health initiatives through government partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

• Phenomune Test Kit A simple, noninvasive taste-based test kit consisting of four taste test strips that measure bitter taste receptor (T2R) phenotype to assess an individual's innate upper respiratory defense capabilities. Requires no samples, no lab work, and provides results within minutes through the paired mobile app. Sold to individual consumers and ordered by healthcare providers and government health departments for patient or population use.
• Phenomune Mobile App A HIPAA-compliant mobile application available on iOS and Android that guides users through the test process, collects taste-strip responses, and delivers personalized immune insights and wellness recommendations within minutes. Distributed via the Apple App Store and Google Play Store for individual consumers, healthcare providers, and Louisiana statewide initiative participants.
• Phenomune Immune Profiling Platform A biotechnology platform combining the Phenomune Test Kit and Mobile App that provides personalized immune insights by measuring bitter taste receptor (T2R) phenotypes linked to innate immune response. The platform enables individual wellness recommendations while supporting population-level health insights for healthcare providers, community clinics, and public health initiatives such as the Louisiana Department of Health program.

Quantifiable outcome

• Up to 250,000 test kits distributed at no cost to Louisiana residents through government partnership
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature4 records

Partnerships

One partnership is on record.

• Louisiana Department of HealthflagshipStrategic or Co-development Partner · 11 June 2026First-of-its-kind statewide population health initiative providing up to 250,000 free immune test kits to Louisiana residents. The program enables participants to assess their innate upper respiratory defense capabilities through a simple taste test and receive personalized insights via the Phenomune app. Backed by Governor Jeff Landry, the initiative aims to reduce healthcare system strain and lower Medicaid costs by enabling proactive, home-based interventions before clinical symptoms manifest. Healthcare providers across care settings can participate by ordering kits for patient populations.

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/phenomune

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phenomune